MedPath

Renal biomarkers in hantavirus infectio

Recruiting
Conditions
N17.9
A98.5
Acute renal failure, unspecified
Haemorrhagic fever with renal syndrome
Registration Number
DRKS00013884
Lead Sponsor
ierenzentrum Heidelberg, Universitätsklinikum Heidelberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

Being able to give consent
- Written consent form of study participants
- Suspicion of Hantavirus infection or proven Hantavirus infection
- Women and men at the age of 18-99 years

Exclusion Criteria

- Non-fulfillment of inclusion criteria
- Refusal of participation

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- Evaluation of renal damage biomarkers concerning their potential to predict a severe disease course during Hantavirus-associated acute kidney injury (AKI). (Measurement 0h/d0 [t0], 24h/d1 [t1], 48h/d2 [t2] and every other day until discharge)<br>- Differentiation of the biomarkers and evaluation of their correlation with laboratory values and cellular substructures. (Measurement 0h/d0 [t0], 24h/d1 [t1], 48h/d2 [t2] and every other day until discharge)
Secondary Outcome Measures
NameTimeMethod
- Comparison of biomarkers with already established, intrinsic markers of renal function and evaluation of their correlation with length of inpatient stay and need for renal replacement therapy. (Measurement 0h/d0 [t0], 24h/d1 [t1], 48h/d2 [t2] and every other day until discharge)<br>- Analysis of potential (clinical) risk factors predisposing for a Hantavirus infection and severe disease courses.<br>- Analysis of different RNA-/DNA-expression patterns/methylation patterns in urine and blood and their correlation with AKI course, multifactorial AKI and hanta virus pathogenesis. (Measurement 0h/d0 [t0], 24h/d1 [t1], 48h/d2 [t2] and every other day until discharge)
© Copyright 2025. All Rights Reserved by MedPath